Feline Dig antibody and antigen (recombinant protein)
Diagnostic anti-Feline Dig antibodies pairs and antigen for animal health (animal Cat/Feline) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-FEL-Dig-Ag01 | Recombinant Feline Dig protein | 3090 |
GMP-FEL-Dig-Ab01 | Anti-Feline Dig mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-Dig-Ab02 | Anti-Feline Dig mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-Dig-Ab03 | Anti-Feline Dig human monoclonal antibody (mAb) | 1953 |
GMP-FEL-Dig-Ab04 | Anti-Feline Dig human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-FEL-Dig-Ag01 |
Product Name | Recombinant Feline Dig protein |
Target/Biomarker | Feline Digoxigenin (Dig) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Feline Digoxigenin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Dig level test of animal Cat/Feline with N/A. |
Tag | His |
Products description | Recombinant Feline Dig protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-Dig-Ab01, GMP-FEL-Dig-Ab02 |
Product Name | Anti-Feline Dig mouse monoclonal antibody (mAb) |
Target/Biomarker | Feline Digoxigenin (Dig) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Feline Digoxigenin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Dig antibodies in Dig level test of animal Cat/Feline with N/A. |
Tag | mFc |
Products description | Anti-Feline Dig mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Dig antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-Dig-Ab03, GMP-FEL-Dig-Ab04 |
Product Name | Anti-Feline Dig human monoclonal antibody (mAb) |
Target/Biomarker | Feline Digoxigenin (Dig) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Feline Digoxigenin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Dig antibodies in Dig level test of animal Cat/Feline with N/A. |
Tag | hFc |
Products description | Anti-Feline Dig human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Dig antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Feline Dig, or digoxin in cats, is a biomarker of paramount importance in veterinary cardiology. It refers to the measurement of digoxin levels in the bloodstream of domestic cats (Felis catus). Digoxin is a cardiac glycoside medication that has been used for decades to treat a variety of heart conditions in both humans and feline patients. Digoxin exerts its therapeutic effects by inhibiting the sodium-potassium pump in cardiac muscle cells. This inhibition leads to an increase in intracellular calcium levels, which, in turn, enhances the force of cardiac muscle contraction while reducing heart rate. In cats with heart conditions such as congestive heart failure (CHF) and specific arrhythmias, digoxin is employed to improve cardiac function, alleviate symptoms, and extend life expectancy. The measurement of Feline Dig serves several crucial purposes. Firstly, it allows veterinarians to ascertain the concentration of digoxin in a cat's bloodstream, which is essential for maintaining the drug within the narrow therapeutic range. Cats, like humans, exhibit individual variability in drug metabolism and sensitivity, making precise dosing a challenge. Feline Dig monitoring ensures that the cat receives an appropriate dosage to achieve therapeutic effects without risking toxicity. Furthermore, Feline Dig measurement aids in assessing the cat's response to digoxin therapy over time. Cardiac conditions are dynamic, and the optimal dosage of digoxin may need adjustments as the cat's condition evolves. By regularly monitoring Feline Dig levels, veterinarians can tailor treatment plans to suit the individual needs of the patient, optimizing both efficacy and safety.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.